On Friday, Anixa Biosciences Inc (NASDAQ: ANIX) opened lower -25.42% from the last session, before settling in for the closing price of $4.8. Price fluctuations for ANIX have ranged from $2.07 to $5.46 over the past 52 weeks.
Healthcare Sector giant saw their annual sales surged by 7.73% over the last five years. Company’s average yearly earnings per share was noted 9.15% at the time writing. With a float of $31.14 million, this company’s outstanding shares have now reached $32.82 million.
Anixa Biosciences Inc (ANIX) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Anixa Biosciences Inc is 5.40%, while institutional ownership is 16.59%. The most recent insider transaction that took place on Jul 31 ’25, was worth 30,800. In this transaction Director of this company bought 10,000 shares at a rate of $3.08, taking the stock ownership to the 953,334 shares. Before that another transaction happened on Jul 30 ’25, when Company’s Chief Executive Officer bought 5,000 for $3.16, making the entire transaction worth $15,800. This insider now owns 579,925 shares in total.
Anixa Biosciences Inc (ANIX) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 10/31/2024, the company posted -0.09 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.11) by 0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.1 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 9.15% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 4.76% during the next five years compared to 7.73% growth over the previous five years of trading.
Anixa Biosciences Inc (NASDAQ: ANIX) Trading Performance Indicators
Check out the current performance indicators for Anixa Biosciences Inc (ANIX). In the past quarter, the stock posted a quick ratio of 8.45.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.34, a number that is poised to hit -0.09 in the next quarter and is forecasted to reach -0.35 in one year’s time.
Technical Analysis of Anixa Biosciences Inc (ANIX)
Analysing the last 5-days average volume posted by the [Anixa Biosciences Inc, ANIX], we can find that recorded value of 1.2 million was better than the volume posted last year of 0.15 million. As of the previous 9 days, the stock’s Stochastic %D was 41.62%.
During the past 100 days, Anixa Biosciences Inc’s (ANIX) raw stochastic average was set at 26.60%, which indicates a significant increase from 3.10% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.42 in the past 14 days, which was higher than the 0.24 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.32, while its 200-day Moving Average is $3.34. Now, the first resistance to watch is $4.61. This is followed by the second major resistance level at $5.65. The third major resistance level sits at $6.19. If the price goes on to break the first support level at $3.03, it is likely to go to the next support level at $2.49. Now, if the price goes above the second support level, the third support stands at $1.45.
Anixa Biosciences Inc (NASDAQ: ANIX) Key Stats
There are currently 32,917K shares outstanding in the company with a market cap of 117.84 million. Presently, the company’s annual sales total 0 K according to its annual income of -12,550 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -2,260 K.
